Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 11:11:92.
doi: 10.1186/1471-2350-11-92.

Low penetrance of a SDHB mutation in a large Dutch paraganglioma family

Affiliations

Low penetrance of a SDHB mutation in a large Dutch paraganglioma family

Frederik J Hes et al. BMC Med Genet. .

Abstract

Background: Germline mutations of the succinate dehydrogenase subunit B gene (SDHB) predispose carriers for paragangliomas, and current estimates of the chance of mutation carriers actually developing tumors (penetrance) are high. We evaluate the phenotype and penetrance of a germline SDHB mutation in a large and clinically well-characterized paraganglioma family.

Methods: Following identification of the mutation in a 31 year old index-patient, extensive clinical screening was performed in mutation carriers to evaluate the presence of head and neck, thoracic and abdominal paragangliomas. Presymptomatic DNA testing was performed in 19 family members.

Results: DNA analysis detected 14 further SDHB mutation carriers. Three mutation carriers (median age 78 years) declined clinical surveillance, but had no clinical signs or symptoms associated with paragangliomas. The remaining 11 mutation carriers (mean age 53, range 37-76 years) consented to clinical screening. In only two, aged 43 and 48 years, were subclinical vagal paragangliomas identified.

Conclusions: Only three of the fifteen mutation carriers in this family have developed paraganglioma, which results in a calculated penetrance of 26% at 48 years of age. This figure is lower than current estimates, and we conclude that the co-operation of this family allowed an almost complete attainment of mutation carriers, and the extensive clinical evaluation carried out allowed us to identify all affected individuals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree with clinical data. The arrow shows the index patient. The non-carriers have been collapsed to minimize recognition of the pedigree.+, mutation present; -, mutation absent; C, clinical screening; N, no symptoms (but not screened); RC, rectal carcinoma; Ov, ovarian carcinoma; EC, endometrial carcinoma; BC, breast cancer (tumors with age at diagnosis in years).
Figure 2
Figure 2
Kaplan-Meier curve of age-related penetrance of SDHB c.423+1G > A carriers. Thin lines represent 95% confidence intervals.

Similar articles

  • The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Kerstens MN, Dreijerink KMA, van Dooren MF, van der Horst-Schrivers ANA, Hes FJ, Leemans CR, Corssmit EPM, Hensen EF. Rijken JA, et al. Clin Genet. 2018 Jan;93(1):60-66. doi: 10.1111/cge.13055. Epub 2017 Sep 6. Clin Genet. 2018. PMID: 28503760
  • The phenotype of SDHB germline mutation carriers: a nationwide study.
    Niemeijer ND, Rijken JA, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, Tops CMJ, van Berkel A, Timmers HJLM, Kunst HPM, Leemans CR, Bisschop PH, Dreijerink KMA, van Dooren MF, Bayley JP, Pereira AM, Jansen JC, Hes FJ, Hensen EF, Corssmit EPM. Niemeijer ND, et al. Eur J Endocrinol. 2017 Aug;177(2):115-125. doi: 10.1530/EJE-17-0074. Epub 2017 May 10. Eur J Endocrinol. 2017. PMID: 28490599
  • Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C; European-American Paraganglioma Study Group. Neumann HP, et al. JAMA. 2004 Aug 25;292(8):943-51. doi: 10.1001/jama.292.8.943. JAMA. 2004. PMID: 15328326
  • A novel germline (c.314T>A) SDHB variant in metastatic paraganglioma: case report and literature review.
    Bernardi S, Zovato S, Pennelli G, Cavallaro M, Rovina M, Dobrinja C, Guglielmi A, Zanconati F, Mazzà D, Nieri A, Bartolomei M, Schiavi F. Bernardi S, et al. Front Endocrinol (Lausanne). 2025 Mar 27;16:1577421. doi: 10.3389/fendo.2025.1577421. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40213107 Free PMC article. Review.
  • Outcomes of SDHB Pathogenic Variant Carriers.
    Davidoff DF, De Abreu Lourenco R, Tsang VHM, Benn DE, Clifton-Bligh RJ. Davidoff DF, et al. J Clin Endocrinol Metab. 2024 Aug 13;109(9):2400-2410. doi: 10.1210/clinem/dgae233. J Clin Endocrinol Metab. 2024. PMID: 38605204 Free PMC article.

Cited by

References

    1. Martin TP, Irving RM, Maher ER. The genetics of paragangliomas: a review. Clin Otolaryngol. 2007;32:7–11. doi: 10.1111/j.1365-2273.2007.01464.x. - DOI - PubMed
    1. Young AL, Baysal BE, Deb A, Young WF. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab. 2002;87:4101–4105. doi: 10.1210/jc.2002-020312. - DOI - PubMed
    1. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292:943–951. doi: 10.1001/jama.292.8.943. - DOI - PubMed
    1. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827–836. doi: 10.1210/jc.2005-1862. - DOI - PubMed
    1. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab. 2006;91:4505–4509. doi: 10.1210/jc.2006-0423. - DOI - PubMed

Substances

LinkOut - more resources